Richard Lumb discusses whether the field of medicine will be ready for patients as they start to demand the use of genomics en masse.
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
We chat with AboGen Co-Founder and CSO Stephen Andrews
We chat with James Sietstra, President of Seven Bridges, about the Cancer Genomics Cloud and enabling collaboration.
US Patent Office declares ‘interference’ between patents from Doudna and Zhang
2016 to see the launch of new Wellcome Genome Campus innovation centre for genomics and biodata businesses.
We chat with Genomics plc CEO John Colenutt about big data and what they’ll be up to Festival of Genomics
Illumina spin-off Grail aims to develop $1000 or less tests for early cancer diagnosis.
Onramp Bioinformatics are creating use-friendly infrastructure for genomic data. CEO and Founder Tim Wesselman explains how.